Neuberger Berman Group (NHS): Forward P/S Multiple

Corporate emblem and logo of Neuberger Berman Fund (NHS)

High-caliber bond analysts, attracted by prestige and bonuses, form the foundation of growth for Neuberger Berman (NHS). The expected P/S ratio confirms this resilience, with the latest reading standing at 10.50. Stability is ensured by active debt management featuring deep risk analysis and the outsourcing of accounting to external market leaders to reduce costs.

Neuberger Berman High Yield Strategies Fund - NHS Market Cap to Future Revenue Ratio (period 07/04/2022 - 09/12/2026)

Analytical breakdowns and data insights for company Neuberger Berman Group (NHS)

- stock price and consensus target price:
Stock Quotes Neuberger Berman High Yield Strategies Fund|NHS - Analyst Consensus Forecast
- stock exchange capitalization data:
Market Capitalization Neuberger Berman Group|NHS - Total Company Value
- issuer book value statistics:
Book Value per Share Neuberger Berman|NHS - Total Stockholders' Equity|Market Value to Book Value Ratio nb.com|NHS - Aggregate Asset Value
- business debt structure and liquidity details:
Total Debt to Capital Neuberger Berman|NHS - Long-Term Indebtedness to Equity|Short-Term Debt to Capital Neuberger Berman|NHS - Company Cumulative Debt|Debt to Book Capitalization Ratio Neuberger Berman Group|NHS - Company Long-Term Loans and Borrowings|Company Current Liabilities Neuberger Berman|Quick Ratio nb.com
- financial results and valuation multiples details:
NHS - Company Net Income|Projected Future Earnings Neuberger Berman|NHS - Market Cap to Earnings|Future Price to Earnings Neuberger Berman Fund|NHS - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Neuberger Berman Group|NHS - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Neuberger Berman|NHS - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months nb.com|NHS - Earnings per share growth this year|Net earnings per share growth forecast for next year Neuberger Berman
- revenue and sales details:
NHS - Company Sales Volume|Projected Sales Volume Neuberger Berman High Yield Strategies Fund|NHS - Market Capitalization-to-Revenue Ratio|Price-to-Projected Revenue Ratio Neuberger Berman Group
Initial company analysis:NHS (Neuberger Berman High Yield Strategies Fund)
Product sample of Neuberger Berman Group

The Neuberger Berman (NHS) strategy to expand municipal bond management and attract private capital directly impacts future revenue dynamics. The projected P/S metric, based on the daily ratio of market capitalization to expected revenue, allows for a real-time assessment of the asset's current margin of safety and identifies fundamental risks or investment opportunities should market conditions shift.

Key competitors

FS Credit Opportunities Corp. - Forward Price-to-Revenue Multiple|Forward P/S Multiple Cohen & Steers Tax-Advantaged Fund PTA|Brookfield Real Assets Fund - Forward P/S Multiple|PAXS: Price-to-Projected Revenue Ratio|NPFD: Forward P/S Multiple|Market Cap to Future Revenue Ratio highlandfunds.com (HFRO)|Price-to-Projected Revenue Ratio Ares Dynamic Credit Allocation Fund|EIC: Forward Price to Sales|Forward P/S Multiple BRW|Nuveen Fund (JGH) - Projected Price to Revenue|Forward P/S Multiple NPCT (Nuveen Core Plus Impact Fund)|Western Asset High Yield Defined Opportunity Fund Inc. (HYI) - Market Cap to Future Revenue Ratio|FTF - Price-to-Projected Revenue Ratio|Forward Price to Sales OPP (RiverNorth/DoubleLine)|HNW (Pioneer Funds) - Forward Price-to-Revenue Multiple|Western Asset Global High Income Fund - Forward Price to Sales|PGZ (Principal Real Estate) - Forward P/S Multiple|Price-to-Projected Revenue Ratio JMM|Forward P/S Multiple CBH|INSI - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Invesco Funds IHTA